Use the Back button in your browser to see the other results of your search or to select another record.
Cost-effectiveness of a graded exercise therapy program for patients with chronic shoulder complaints |
Geraets J, Goossens M, de Bruijn CPC, de Groot IJM, Koke AJS, Pelt R, van der Heijden G, Dinant GJ, van den Heuvel WJA |
International Journal of Technology Assessment in Health Care 2006 Jan;22(1):76-83 |
clinical trial |
6/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
OBJECTIVES: The present study evaluated the cost-effectiveness of a behavioral graded exercise therapy (GET) program compared with usual care (UC) in terms of the performance of daily activities by patients with chronic shoulder complaints in primary care. METHODS: A total of 176 patients were randomly assigned either to GET (n = 87) or to UC (n = 89). Clinical outcomes (main complaints, shoulder disability (SDQ) and generic health-related quality of life (EQ-5D), and costs (intervention costs, direct health care costs, direct non-health-related costs, and indirect costs)) were assessed during the 12-week treatment period and at 52 weeks of follow-up. RESULTS: Results showed that GET was more effective than UC in restoring daily activities as assessed by the main complaints instrument after the 12-week treatment period (p = 0.049; mean difference, 7.5; confidence interval (CI) 0.0 to 15.0). These effects lasted for at least 52 weeks (p = 0.025; mean difference 9.2; CI 1.2 to 17.3). No statistically significant differences were found on the SDQ or EQ5D. GET significantly reduced direct health care costs (p = 0.000) and direct non-health care costs (p = 0.029). Nevertheless, total costs during the 1-year follow-up period were significantly higher (p = 0.001; GET Euro 530 versus UC Euro 377) due to the higher costs of the intervention. Incremental cost-effectiveness ratios for the main complaints (0 to 100), SDQ (0 to 100), and EQ-5D (-1.0 to 1.0) were Euro 17, Euro 74, and Euro 5,278 per unit of improvement, respectively. CONCLUSIONS: GET proved to be more effective in the short- and long-term and reduces direct health care costs and direct non-health care costs but is associated with higher costs of the intervention itself.
|